213 related articles for article (PubMed ID: 23213667)
1. Transmission assessment surveys in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement.
Wkly Epidemiol Rec; 2012 Nov; 87(48):478-82. PubMed ID: 23213667
[No Abstract] [Full Text] [Related]
2. Global Programme to eliminate lymphatic filariasis: progress report on mass drug administration, 2010.
Wkly Epidemiol Rec; 2011 Aug; 86(35):377-88. PubMed ID: 21887884
[No Abstract] [Full Text] [Related]
3. Global programme to eliminate lymphatic filariasis: progress report, 2011.
Wkly Epidemiol Rec; 2012 Sep; 87(37):346-56. PubMed ID: 22977953
[No Abstract] [Full Text] [Related]
4. Global programme to eliminate lymphatic filariasis: progress report for 2012.
Wkly Epidemiol Rec; 2013 Sep; 88(37):389-99. PubMed ID: 24073461
[No Abstract] [Full Text] [Related]
5. [Lymphatic filariasis].
Sante; 2000; 10(5):360-1. PubMed ID: 11221698
[No Abstract] [Full Text] [Related]
6. Global programme to eliminate lymphatic filariasis.
Wkly Epidemiol Rec; 2009 Oct; 84(42):437-44. PubMed ID: 19860021
[No Abstract] [Full Text] [Related]
7. Global programme to eliminate lymphatic filariasis.
Wkly Epidemiol Rec; 2010 Sep; 85(38):365-72. PubMed ID: 20853547
[No Abstract] [Full Text] [Related]
8. Lymphatic filariasis.
Wkly Epidemiol Rec; 2003 May; 78(20):171-9. PubMed ID: 12808788
[No Abstract] [Full Text] [Related]
9. Elimination of transmission of lymphatic filariasis in Egypt.
Molyneux DH
Lancet; 2006 Mar; 367(9515):966-8. PubMed ID: 16564345
[No Abstract] [Full Text] [Related]
10. Managing morbidity and preventing disability in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement.
Wkly Epidemiol Rec; 2011 Dec; 86(51-52):581-5. PubMed ID: 22191103
[No Abstract] [Full Text] [Related]
11. The development of albendazole for lymphatic filariasis.
Horton J
Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S33-40. PubMed ID: 19843396
[TBL] [Abstract][Full Text] [Related]
12. 489 Global programme to eliminate lymphatic filariasis: progress report, 2014.
Wkly Epidemiol Rec; 2015 Sep; 90(38):489-504. PubMed ID: 26387149
[No Abstract] [Full Text] [Related]
13. The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
Hooper PJ; Bradley MH; Biswas G; Ottesen EA
Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S17-21. PubMed ID: 19843394
[TBL] [Abstract][Full Text] [Related]
14. Lymphatic filariasis elimination: progress in global programme development.
Molyneux DH; Zagaria N
Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S15-40. PubMed ID: 12630391
[No Abstract] [Full Text] [Related]
15. Mass drug treatment for lymphatic filariasis and onchocerciasis.
Molyneux DH; Bradley M; Hoerauf A; Kyelem D; Taylor MJ
Trends Parasitol; 2003 Nov; 19(11):516-22. PubMed ID: 14580963
[No Abstract] [Full Text] [Related]
16. Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis.
Wkly Epidemiol Rec; 2004 Oct; 79(40):358-65. PubMed ID: 15631012
[No Abstract] [Full Text] [Related]
17. Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
Nandha B; Krishnamoorthy K; Jambulingam P
Health Educ Res; 2013 Aug; 28(4):591-8. PubMed ID: 23503571
[TBL] [Abstract][Full Text] [Related]
18. [Lymphatic filariasis transmission assessment survey in schools three years after stopping mass drug treatment with albendazole and ivermectin in the 7 endemic districts in Togo].
Dorkenoo AM; Sodahlon YK; Bronzan RN; Yakpa K; Sossou E; Ouro-Medeli A; Teko M; Seim A; Mathieu E
Bull Soc Pathol Exot; 2015 Aug; 108(3):181-7. PubMed ID: 25476256
[TBL] [Abstract][Full Text] [Related]
19. GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis.
Gustavsen KM; Bradley MH; Wright AL
Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S11-5. PubMed ID: 19843393
[TBL] [Abstract][Full Text] [Related]
20. Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.
Burkot TR; Taleo G; Toeaso V; Ichimori K
Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S61-9. PubMed ID: 12625919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
